TrialThe New England journal of medicine2020
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
Richard S Finn et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4,632 papers cite itlatest 60 shown
this paperpooled ittrialcites it